Slate Path Capital LP - Q3 2019 holdings

$1.51 Billion is the total value of Slate Path Capital LP's 29 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 56.7% .

 Value Shares↓ Weighting
SNAP SellSNAP INCcl a$228,152,000
-15.6%
14,440,000
-23.6%
15.11%
+24.5%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$193,284,000
-4.7%
469,000
-8.6%
12.80%
+40.7%
MDCO BuyMEDICINES CO$184,750,000
+42.9%
3,695,000
+4.2%
12.23%
+111.0%
GOLD SellBARRICK GOLD CORPORATION$169,747,000
-13.3%
9,795,000
-21.1%
11.24%
+28.0%
NYT BuyNEW YORK TIMES COcl a$144,821,000
+17.1%
5,085,000
+34.2%
9.59%
+72.9%
KEX  KIRBY CORP$112,148,000
+4.0%
1,365,0000.0%7.42%
+53.5%
GE  GENERAL ELECTRIC CO$92,529,000
-14.9%
10,350,0000.0%6.13%
+25.7%
Z BuyZILLOW GROUP INCcl c cap stk$87,224,000
-29.4%
2,925,000
+9.8%
5.78%
+4.1%
MOS BuyMOSAIC CO NEW$86,715,000
+17.2%
4,230,000
+43.1%
5.74%
+73.1%
PAAS BuyPAN AMERICAN SILVER CORP$56,448,000
+112.3%
3,600,000
+74.8%
3.74%
+213.3%
ALNY  ALNYLAM PHARMACEUTICALS INC$49,458,000
+10.8%
615,0000.0%3.28%
+63.7%
INTEQ NewINTELSAT S A$25,080,0001,100,000
+100.0%
1.66%
EEM BuyISHARES TRcall$13,610,000
+237.4%
333,000
+254.3%
0.90%
+397.8%
SBGL BuySIBANYE STILLWATERsponsored adr$13,480,000
+406.8%
2,496,253
+345.8%
0.89%
+650.4%
CYCN BuyCYCLERION THERAPEUTICS INC$10,666,000
+30.5%
880,000
+23.2%
0.71%
+92.4%
RETA NewREATA PHARMACEUTICALS INCcl a$9,635,000120,000
+100.0%
0.64%
CUE NewCUE BIOPHARMA INC$7,503,000890,000
+100.0%
0.50%
ZG  ZILLOW GROUP INCcl a$5,466,000
-35.4%
185,0000.0%0.36%
-4.7%
QQQ SellINVESCO QQQ TRcall$3,965,000
-62.4%
21,000
-62.8%
0.26%
-44.4%
APRN NewBLUE APRON HLDGS INCcl a new$2,698,000320,000
+100.0%
0.18%
LX NewLEXINFINTECH HLDGS LTDadr$2,257,000225,000
+100.0%
0.15%
PDD NewPINDUODUO INCsponsored ads$2,094,00065,000
+100.0%
0.14%
FCX NewFREEPORT-MCMORAN INCcl b$1,770,000185,000
+100.0%
0.12%
SNAP SellSNAP INCcall$1,738,000
-55.0%
110,000
-59.3%
0.12%
-33.5%
TDW  TIDEWATER INC NEW$1,662,000
-35.7%
110,0000.0%0.11%
-5.2%
AG  FIRST MAJESTIC SILVER CORP$1,545,000
+14.9%
170,0000.0%0.10%
+70.0%
SDRLF  SEADRILL LTD$819,000
-49.5%
390,0000.0%0.05%
-26.0%
MDRIQ NewMCDERMOTT INTL INC$586,000290,000
+100.0%
0.04%
X SellUNITED STATES STL CORP NEW$462,000
-85.6%
40,000
-81.0%
0.03%
-78.5%
GPRE ExitGREEN PLAINS INC$0-282,000
-100.0%
-0.14%
CTVA ExitCORTEVA INC$0-110,000
-100.0%
-0.15%
WPM ExitWHEATON PRECIOUS METALS CORP$0-155,000
-100.0%
-0.17%
CF ExitCF INDS HLDGS INC$0-101,000
-100.0%
-0.21%
GDX ExitVANECK VECTORS ETF TRgold miners etf$0-1,000,000
-100.0%
-1.15%
UBER ExitUBER TECHNOLOGIES INC$0-810,000
-100.0%
-1.68%
LYFT ExitLYFT INC$0-615,000
-100.0%
-1.81%
ALLY ExitALLY FINL INC$0-2,310,000
-100.0%
-3.21%
SPY ExitSPDR S&P 500 ETF TRcall$0-2,000,000
-100.0%
-26.28%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings